Farmacia y Biotecnología archivos

Miraculins Announces Issuance of Independent Analyst’s Research Report from New York Based RB Milestone Group

22 agosto, 2013admin

Internacional (Marketwired, 22 de Agosto de 2013) Miraculins Inc. (TSX VENTURE:MOM), ("Miraculins" or the "Company") a medical diagnostic company focused on acquiring, developing and commercializing diagnostic and risk assessment technologies for unmet clinical needs, announces today that an independent analyst's research report has been issued by New York based RB Milestone Group, LLC ("RB Milestone").

RedXDefense’s XCAT Verified for Use in a Presumptive Drug Field Testing Program

22 agosto, 2013admin

Internacional (Marketwired, 22 de Agosto de 2013) Narcotics, Explosives, and Gunshot Residue Detection System Receives High Marks From Independent Lab

SKTO Announces Acquisition of Accomplished Medical Cannabis Consulting Firm

16 agosto, 2013admin

Internacional (Marketwired, 16 de Agosto de 2013) SK3 Group, Inc. (PINKSHEETS: SKTO) (SK3) announces that it has signed a definitive agreement to acquire Sovereign International, Inc., a full service medical cannabis consulting firm specializing in advising on cultivation techniques. Through a unique cultivation technique, including locating but not tampering with the genetics of the first generation OG Kush strain, Sovereign has played a vital role in building the household strain name "Sovereign OG." Sovereign has perfected this particular strain to have some of the most potent medicinal benefits for a wide range of ailments the symptoms for which research has shown will be alleviated by medical marijuana. Sovereign has worked with over 300 collectives in Southern California with some of the most discerning connoisseurs and a wide range of members that prefer, and are loyal consumers of, the "Sovereign OG" brand.

Bio-Matrix Scientific Group Discusses Regen BioPharma’s Cancer Immunotherapy Program

16 agosto, 2013admin

Internacional (Marketwired, 16 de Agosto de 2013) Benitec IP Deal Provides International Patent Protection for Novel Cancer Immune Therapy

iSatori’s New Bio-Gro?, Powered by Bioactive Peptides, Creates an Entirely New Product Category With Europa Sports, America’s Largest Wholesale Distributor of Sports Nutrition

16 agosto, 2013admin

Internacional (Marketwired, 16 de Agosto de 2013) First New Sports Nutrition Category in Over Ten Years Helps Individuals Develop Lean Muscle and Recover From Intense Workouts Faster Than the Body Can on Its Own

MIT Holding, Inc. (MITD) Announces Negotiations With Leading Private Duty Care and Services Company

16 agosto, 2013admin

Internacional (Marketwired, 16 de Agosto de 2013) MIT HOLDING, INC. (OTCQB: MITD) announces that it has begun negotiations with a leading South Eastern US private duty care services company. Assisting the in home needs of the elderly and other home bound medical patients, management believes the transaction will close in the next 60 days.

Brazil Interactive Media Reports 2nd Quarter 2013 Financial Results

16 agosto, 2013admin

COLOMBIA (Marketwired, 16 de Agosto de 2013) Revenue Increases 88% for Quarter Ended June 30, 2013 vs. 2012

Global Companion Biomarker Market to Catapult to $319 Million by 2018

15 agosto, 2013admin

Internacional (Marketwired, 15 de Agosto de 2013) TriMarkPublications.com cites in its newly published "Companion Biomarkers in Drug Development" report that the global companion biomarker market will catapult to $319 million by 2018. For more information, visit: http://www.trimarkpublications.com/companion-biomarkers-in-drug-development/.

NCPDP Announces Electronic Prior Authorization Webinar on August 22nd

15 agosto, 2013admin

Internacional (Marketwired, 15 de Agosto de 2013) Educational Webinar to Provide an Overview of Electronic Prior Authorization (ePA) Transactions in SCRIPT Standard

Mincom Capital Inc. Terminates Letter of Intent With Group Nanoxplore Inc.

13 agosto, 2013admin

Internacional (Marketwired, 13 de Agosto de 2013) Mincom Capital Inc. ("Mincom") (TSX VENTURE:MOI) and Group Nanoxplore Inc. ("Nanoxplore") announce the termination of the letter of intent dated March 28, 2013 and signed by Nanoxplore on April 3, 2013 (the "LOI"). The termination of the LOI follows confirmation from the TSX Venture Exchange (the "Exchange") on August 1, 2013 that the resulting issuer, pursuant to the proposed Qualifying Transaction, did not have a sufficient "history of operations and validity of business" required to satisfy the Exchange's minimum initial listing requirements.